January 5, 2017 Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
Critical Path Institute and TGen Forge Partnership to Advance TB Research May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1,
Critical Path Institute Launches Transplant Therapeutics Consortium April 26, 2017 Critical Path Institute Launches Transplant Therapeutics Consortium Tucson, Ariz., April 26, 2017 –Critical Path
April 21, 2017 Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
CDISC Announces New Standard for Major Depressive Disorder to Foster Development of New Treatments April 18, 2017 CDISC Announces New Standard for Major Depressive Disorder to Foster Development of New Treatments Austin, T
New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need
PTC Meets Its Deliverables April 11, 2017 Dear Colleagues, In the fall of 2015 C-Path established the Pediatric Trials Consortium (PTC), with the go
Response of Novel Skeletal Muscle Biomarkers in Dogs to Drug-Induced Skeletal Muscle Injury or Sustained Endurance Exercise
